These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 23728165)

  • 21. Treatment of refractory paediatric giardiasis using secnidazole plus albendazole: a case series.
    Escobedo AA; Almirall P; Chirino E; Pacheco F; Duque A; Avila I
    Infez Med; 2018 Dec; 26(4):379-384. PubMed ID: 30555145
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Giardiasis: An Overview.
    Leung AKC; Leung AAM; Wong AHC; Sergi CM; Kam JKM
    Recent Pat Inflamm Allergy Drug Discov; 2019; 13(2):134-143. PubMed ID: 31210116
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Giardiasis in a hematopoietic stem cell transplant patient.
    Ajumobi AB; Daniels JA; Sostre CF; Trevino HH
    Transpl Infect Dis; 2014 Dec; 16(6):984-7. PubMed ID: 25065269
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mebendazole as an alternative in Giardia duodenalis infection.
    Cañete R
    West Indian Med J; 2013 Feb; 62(2):165-7. PubMed ID: 24564073
    [No Abstract]   [Full Text] [Related]  

  • 25. A meta-analysis of the effectiveness of albendazole compared with metronidazole as treatments for infections with Giardia duodenalis.
    Solaymani-Mohammadi S; Genkinger JM; Loffredo CA; Singer SM
    PLoS Negl Trop Dis; 2010 May; 4(5):e682. PubMed ID: 20485492
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Giardia Lamblia Subtypes and Their Relationship with Clinical Symptoms in Patients with Giardiasis.
    Viesy S; Abdi J; Haghani K; Valizadeh R; Mirzaei A
    Infect Disord Drug Targets; 2020; 20(3):396-400. PubMed ID: 30868967
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of albendazole in giardiasis.
    Baqai R; Zuberi SJ; Qureshi H; Ahmed W; Hafiz S
    East Mediterr Health J; 2001; 7(4-5):787-90. PubMed ID: 15332780
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Drugs for treating giardiasis.
    Granados CE; Reveiz L; Uribe LG; Criollo CP
    Cochrane Database Syst Rev; 2012 Dec; 12(12):CD007787. PubMed ID: 23235648
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Giardia lamblia in Mongolian gerbils: characteristics of infection using different human isolates.
    Bouza M; Maciques I; Torres D; Núñez FA
    Exp Parasitol; 2000 Sep; 96(1):43-6. PubMed ID: 11038319
    [No Abstract]   [Full Text] [Related]  

  • 30. Chronic giardiasis: studies on drug sensitivity, toxin production, and host immune response.
    Smith PD; Gillin FD; Spira WM; Nash TE
    Gastroenterology; 1982 Oct; 83(4):797-803. PubMed ID: 7106510
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Randomized clinical study of nitazoxanide compared to metronidazole in the treatment of symptomatic giardiasis in children from Northern Peru.
    Ortiz JJ; Ayoub A; Gargala G; Chegne NL; Favennec L
    Aliment Pharmacol Ther; 2001 Sep; 15(9):1409-15. PubMed ID: 11552913
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of Giardia lamblia on growth, serum levels of zinc, copper, and iron in Egyptian children.
    Abou-Shady O; El Raziky MS; Zaki MM; Mohamed RK
    Biol Trace Elem Res; 2011 Apr; 140(1):1-6. PubMed ID: 20340051
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Therapy-resistant diarrhea due to Giardia lamblia in a patient with common variable immunodeficiency disease.
    Sawatzki M; Peter S; Hess C
    Digestion; 2007; 75(2-3):101-2. PubMed ID: 17598960
    [No Abstract]   [Full Text] [Related]  

  • 34. Effect of probiotic Saccharomyces boulardii in experimental giardiasis.
    Ribeiro MRS; Oliveira DR; Oliveira FMS; Caliari MV; Martins FS; Nicoli JR; Torres MF; Andrade MER; Cardoso VN; Gomes MA
    Benef Microbes; 2018 Sep; 9(5):789-797. PubMed ID: 30165752
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Giardiasis treatment: an update with a focus on refractory disease.
    Mørch K; Hanevik K
    Curr Opin Infect Dis; 2020 Oct; 33(5):355-364. PubMed ID: 32773501
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An up-date on Giardia and giardiasis.
    Einarsson E; Ma'ayeh S; Svärd SG
    Curr Opin Microbiol; 2016 Dec; 34():47-52. PubMed ID: 27501461
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cryptosporidium and Giardia Infections in Children: A Review.
    Mmbaga BT; Houpt ER
    Pediatr Clin North Am; 2017 Aug; 64(4):837-850. PubMed ID: 28734513
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nitroimidazole-refractory giardiasis: a growing problem requiring rational solutions.
    Carter ER; Nabarro LE; Hedley L; Chiodini PL
    Clin Microbiol Infect; 2018 Jan; 24(1):37-42. PubMed ID: 28624613
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Saccharomyces boulardii as therapeutic alternative in experimental giardiasis.
    Ribeiro MRS; Oliveira DR; Caliari MV; Cara Machado DC; Andrade MER; Cardoso VN; Dos Santos Martins F; Nicoli JR; Gomes MA
    J Appl Microbiol; 2021 Jul; 131(1):460-469. PubMed ID: 33289232
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A reprofiled drug, auranofin, is effective against metronidazole-resistant Giardia lamblia.
    Tejman-Yarden N; Miyamoto Y; Leitsch D; Santini J; Debnath A; Gut J; McKerrow JH; Reed SL; Eckmann L
    Antimicrob Agents Chemother; 2013 May; 57(5):2029-35. PubMed ID: 23403423
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.